Interview With Janssen Doctor Explores Potential Bladder Cancer

Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.

CME; solid tumors, HER2, T-DXd, endometrial, cervical

Discussing tools and resources to support the bladder cancer patient community

Molecular and histopathology directed therapy for advanced bladder cancer

Understanding the current medical landscape of prostate cancer

Paige and Janssen Deploy AI Based Biomarker Test For Bladder Cancer

Cancers, Free Full-Text

Interview With Janssen Doctor Explores Potential Bladder Cancer Treatment Options

Advances in immunotherapies and targeted treatments for patients with bladder cancer: An update from ESMO 2022 - touchONCOLOGY

Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy

Luca Dezzani on LinkedIn: #wclc22

Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)

Frontiers HER2 expression in urothelial carcinoma, a systematic literature review

Rectal Cancer Disappears After Experimental Use of Immunotherapy